Your browser doesn't support javascript.
loading
Anxiety in late-life depression: Associations with brain volume, amyloid beta, white matter lesions, cognition, and functional ability.
Kryza-Lacombe, Maria; Kassel, Michelle T; Insel, Philip S; Rhodes, Emma; Bickford, David; Burns, Emily; Butters, Meryl A; Tosun, Duygu; Aisen, Paul; Raman, Rema; Landau, Susan; Saykin, Andrew J; Toga, Arthur W; Jack, Clifford R; Koeppe, Robert; Weiner, Michael W; Nelson, Craig; Mackin, R Scott.
Afiliación
  • Kryza-Lacombe M; Mental Illness Research Education and Clinical Centers, Veterans Affairs Medical Center, San Francisco, CA, USA.
  • Kassel MT; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, CA, USA.
  • Insel PS; Mental Illness Research Education and Clinical Centers, Veterans Affairs Medical Center, San Francisco, CA, USA.
  • Rhodes E; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, CA, USA.
  • Bickford D; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, CA, USA.
  • Burns E; Mental Illness Research Education and Clinical Centers, Veterans Affairs Medical Center, San Francisco, CA, USA.
  • Butters MA; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, CA, USA.
  • Tosun D; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, CA, USA.
  • Aisen P; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, CA, USA.
  • Raman R; Department of Psychiatry Western Psychiatric Hospital, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Landau S; Veterans Affairs Medical Center, San Francisco, CA, USA.
  • Saykin AJ; Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA, USA.
  • Toga AW; University of Southern California, Los Angeles, CA, USA.
  • Jack CR; Keck School of Medicine, Alzheimer's Therapeutic Research Institute, University of Southern California, San Diego, CA, USA.
  • Koeppe R; University of Southern California, Los Angeles, CA, USA.
  • Weiner MW; Keck School of Medicine, Alzheimer's Therapeutic Research Institute, University of Southern California, San Diego, CA, USA.
  • Nelson C; Helen Wills Neuroscience Institute, University of California, Berkeley, CA, USA.
  • Mackin RS; Department of Radiology and Imaging Sciences and the Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, IN, USA.
Int Psychogeriatr ; : 1-12, 2024 Jan 25.
Article en En | MEDLINE | ID: mdl-38268483
ABSTRACT

OBJECTIVES:

Late-life depression (LLD) is common and frequently co-occurs with neurodegenerative diseases of aging. Little is known about how heterogeneity within LLD relates to factors typically associated with neurodegeneration. Varying levels of anxiety are one source of heterogeneity in LLD. We examined associations between anxiety symptom severity and factors associated with neurodegeneration, including regional brain volumes, amyloid beta (Aß) deposition, white matter disease, cognitive dysfunction, and functional ability in LLD. PARTICIPANTS AND MEASUREMENTS Older adults with major depression (N = 121, Ages 65-91) were evaluated for anxiety severity and the following brain volume (orbitofrontal cortex [OFC], insula), cortical Aß standardized uptake value ratio (SUVR), white matter hyperintensity (WMH) volume, global cognition, and functional ability. Separate linear regression analyses adjusting for age, sex, and concurrent depression severity were conducted to examine associations between anxiety and each of these factors. A global regression analysis was then conducted to examine the relative associations of these variables with anxiety severity.

RESULTS:

Greater anxiety severity was associated with lower OFC volume (ß = -68.25, t = -2.18, p = .031) and greater cognitive dysfunction (ß = 0.23, t = 2.46, p = .016). Anxiety severity was not associated with insula volume, Aß SUVR, WMH, or functional ability. When examining the relative associations of cognitive functioning and OFC volume with anxiety in a global model, cognitive dysfunction (ß = 0.24, t = 2.62, p = .010), but not OFC volume, remained significantly associated with anxiety.

CONCLUSIONS:

Among multiple factors typically associated with neurodegeneration, cognitive dysfunction stands out as a key factor associated with anxiety severity in LLD which has implications for cognitive and psychiatric interventions.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Int Psychogeriatr Asunto de la revista: GERIATRIA / PSIQUIATRIA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Int Psychogeriatr Asunto de la revista: GERIATRIA / PSIQUIATRIA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos